MAAT — Maat Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00- €124.02m
- €116.49m
- €4.52m
Annual cashflow statement for Maat Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.02 | -13.7 | -19.7 | -28.9 | -31.1 |
| Depreciation | |||||
| Non-Cash Items | 0.971 | 0.728 | 0.561 | 1.79 | 2.72 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.208 | -0.05 | -0.384 | 3.38 | 10.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.93 | -12.6 | -18.7 | -22 | -15.7 |
| Capital Expenditures | -0.238 | -0.662 | -1.09 | -0.753 | -0.608 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -0.153 | 0.653 | 0.337 | 0.338 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.238 | -0.815 | -0.44 | -0.416 | -0.27 |
| Financing Cash Flow Items | -0.392 | -0.151 | -0.179 | -0.468 | -0.42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.6 | 5.36 | 8.14 | 18.3 | 20.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 23.4 | -8.06 | -11 | -4.13 | 4.71 |